{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:30:31Z","timestamp":1760401831658,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.7759\/cureus.94452","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T11:17:51Z","timestamp":1760354271000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Unprovoked Pulmonary Embolism As the First Presentation in Undiagnosed Acromegaly"],"prefix":"10.7759","author":[{"given":"Saad","family":"Muhammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aly","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annzel","family":"Jais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumaya","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yorissa","family":"Padayachee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed S","year":"2006","unstructured":"Melmed S. Acromegaly. N Engl J Med. 2006, 355:2558-73. 10.1056\/NEJMra062453","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki A","year":"2017","unstructured":"Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017, 20:4-9. 10.1007\/s11102-016-0754-x","journal-title":"Pituitary"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2149","article-title":"Extensive clinical experience: changing patterns in diagnosis and therapy of acromegaly over two decades","volume":"93","author":"Nachtigall L","year":"2008","unstructured":"Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A. Extensive clinical experience: changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab. 2008, 93:2035-41. 10.1210\/jc.2007-2149","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0789-7","article-title":"The genetic background of acromegaly","volume":"20","author":"Gadelha MR","year":"2017","unstructured":"Gadelha MR, Kasuki L, Korbonits M. The genetic background of acromegaly. Pituitary. 2017, 20:10-21. 10.1007\/s11102-017-0789-7","journal-title":"Pituitary"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey PL","year":"2023","unstructured":"Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023, 20:248-62. 10.1038\/s41569-022-00787-6","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.d01-1743.x","article-title":"Elevated fibrinogen levels decrease following treatment of acromegaly","volume":"46","author":"Landin-Wilhelmsen K","year":"1997","unstructured":"Landin-Wilhelmsen K, Tengborn L, Wilhelmsen L, Bengtsson BA. Elevated fibrinogen levels decrease following treatment of acromegaly. Clin Endocrinol (Oxf). 1997, 46:69-74. 10.1046\/j.1365-2265.1997.d01-1743.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4158\/EP.13.4.363","article-title":"Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly","volume":"13","author":"Vilar L","year":"2007","unstructured":"Vilar L, Naves LA, Costa SS, Abdalla LF, Coelho CE, Casulari LA. Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly. Endocr Pract. 2007, 13:363-72. 10.4158\/EP.13.4.363","journal-title":"Endocr Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0300-0","article-title":"Coagulation parameters and platelet function analysis in patients with acromegaly","volume":"39","author":"Colak A","year":"2016","unstructured":"Colak A, Y\u0131lmaz H, Temel Y, et al.. Coagulation parameters and platelet function analysis in patients with acromegaly. J Endocrinol Invest. 2016, 39:97-101. 10.1007\/s40618-015-0300-0","journal-title":"J Endocrinol Invest"},{"key":"ref9","article-title":"A case of acromegaly with thrombosis and embolism","volume":"10","author":"Coffey WB","year":"1912","unstructured":"Coffey WB, Cummins WT. A case of acromegaly with thrombosis and embolism. Cal State J Med. 1912, 10:341-3.","journal-title":"Cal State J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.911572","article-title":"Massive pulmonary embolism as the initial presentation of acromegaly: is acromegaly a hypercoagulable condition?","volume":"19","author":"Elarabi AM","year":"2018","unstructured":"Elarabi AM, Mosleh E, Alamlih LI, Albakri MM, Ibrahim WH. Massive pulmonary embolism as the initial presentation of acromegaly: is acromegaly a hypercoagulable condition?. Am J Case Rep. 2018, 19:1541-5. 10.12659\/AJCR.911572","journal-title":"Am J Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8867","article-title":"Unexplained massive pulmonary embolism in acromegaly patient: a case report","volume":"12","author":"Al-Anbagi U","year":"2024","unstructured":"Al-Anbagi U, Usman S, Saad A, Nashwan AJ. Unexplained massive pulmonary embolism in acromegaly patient: a case report. Clin Case Rep. 2024, 12:e8867. 10.1002\/ccr3.8867","journal-title":"Clin Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal J","year":"2016","unstructured":"Dal J, Feldt-Rasmussen U, Andersen M, et al.. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol. 2016, 175:181-90. 10.1530\/EJE-16-0117","journal-title":"Eur J Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01186-9","article-title":"The haemostatic system in acromegaly: a single-centre case-control study","volume":"43","author":"Campello E","year":"2020","unstructured":"Campello E, Marobin M, Barbot M, et al.. The haemostatic system in acromegaly: a single-centre case-control study. J Endocrinol Invest. 2020, 43:1009-18. 10.1007\/s40618-020-01186-9","journal-title":"J Endocrinol Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf139","article-title":"Venous thromboembolism in patients with pituitary adenoma: UK multicentre cohort study","volume":"193","author":"Isand K","year":"2025","unstructured":"Isand K, Pofi R, Haermson O, et al.. Venous thromboembolism in patients with pituitary adenoma: UK multicentre cohort study. Eur J Endocrinol. 2025, 193:270-7. 10.1093\/ejendo\/lvaf139","journal-title":"Eur J Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0817","article-title":"Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications","volume":"182","author":"Kyriakakis N","year":"2020","unstructured":"Kyriakakis N, Pechlivani N, Lynch J, et al.. Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications. Eur J Endocrinol. 2020, 182:511-21. 10.1530\/EJE-19-0817","journal-title":"Eur J Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-008-9088-4","article-title":"Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI","volume":"33","author":"Erem C","year":"2008","unstructured":"Erem C, Nuhoglu I, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI. Endocrine. 2008, 33:270-6. 10.1007\/s12020-008-9088-4","journal-title":"Endocrine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00437","article-title":"The endothelium in acromegaly","volume":"10","author":"Maffei P","year":"2019","unstructured":"Maffei P, Dassie F, Wennberg A, Parolin M, Vettor R. The endothelium in acromegaly. Front Endocrinol (Lausanne). 2019, 10:437. 10.3389\/fendo.2019.00437","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2021.101391","article-title":"The association between treatment and systemic inflammation in acromegaly","volume":"57-58","author":"Wolters TL","year":"2021","unstructured":"Wolters TL, van der Heijden CD, Pinzariu O, et al.. The association between treatment and systemic inflammation in acromegaly. Growth Horm IGF Res. 2021, 57-58:101391. 10.1016\/j.ghir.2021.101391","journal-title":"Growth Horm IGF Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14061906","article-title":"Acromegaly and cardiovascular disease: associated cardiovascular risk factors, cardiovascular prognosis, and therapeutic impact","volume":"14","author":"Iglesias P","year":"2025","unstructured":"Iglesias P. Acromegaly and cardiovascular disease: associated cardiovascular risk factors, cardiovascular prognosis, and therapeutic impact. J Clin Med. 2025, 14:1906. 10.3390\/jcm14061906","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.09.014","article-title":"Cardiovascular disorders associated with acromegaly: an update","volume":"30","author":"Sherin RP","year":"2024","unstructured":"Sherin RP, Vietor NO, Usman A, Hoang TD, Shakir MK. Cardiovascular disorders associated with acromegaly: an update. Endocr Pract. 2024, 30:1212-9. 10.1016\/j.eprac.2024.09.014","journal-title":"Endocr Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421555-acute-unprovoked-pulmonary-embolism-as-the-first-presentation-in-undiagnosed-acromegaly","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T11:17:52Z","timestamp":1760354272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421555-acute-unprovoked-pulmonary-embolism-as-the-first-presentation-in-undiagnosed-acromegaly"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.94452","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}